Thousands of individuals have initiated legal proceedings against Johnson & Johnson, alleging that the company knowingly sold talc-based baby powder contaminated with asbestos in the UK. Approximately 3,000 plaintiffs claim they or a family member developed ovarian cancer or mesothelioma as a result of using the product, seeking over £1 billion in damages through the high court in London.
The legal representatives for the claimants argue that Johnson & Johnson, along with its subsidiaries, should be held accountable for these alleged health risks. They assert that the company concealed information about potential dangers associated with the product for decades. In recent years, Johnson & Johnson transitioned from using talc to corn starch and ceased global production of talc-based baby powder in 2023, three years after discontinuing sales in the US and Canada.
Johnson & Johnson has denied the allegations, stating that the talc used in baby powder met regulatory standards, did not contain asbestos, and was not linked to cancer. The talc is a naturally occurring mineral, and concerns have been raised regarding the presence of asbestos in many globally exploited talc deposits. Rawlinson KC, representing the plaintiffs, claims there is minimal likelihood of talc deposits without asbestos and contends that Johnson & Johnson suppressed information regarding contamination risks.
Additionally, the method of applying baby powder, which often creates airborne particles, raises questions about potential inhalation. Testimonies from affected individuals highlight personal health struggles, notably those who have used the product for many years.
Kenvue, the division formerly responsible for consumer health products, reaffirmed its commitment to product safety based on extensive testing conducted by independent entities. They stated that the talc in Johnson’s Baby Powder complied with safety regulations. The legal proceedings continue to unfold, calling attention to significant health issues associated with the product.
Source: https://www.theguardian.com/business/2025/oct/16/thousands-in-uk-open-case-against-johnson-johnson-over-alleged-talcum-powder-cancer-link